Adline Chem Lab
Healthcare
524604 BSE
Price unavailable
Close 12 Oct 2026 ₹15.79 +1.64 +11.6% since 10 Nov 2025
Start ₹14.15
Key Fundamentals
MicrocapPharmaceuticals & BiotechnologyHealthcarePrice-based figures · EPS basis: Standalone · TTM
- ROCE
- Not meaningful: the figure is far outside this ratio’s usual range, as its base is close to zero
- Debt to Equity
- Not meaningful: shareholders’ equity is negative
- EPS (TTM)
- −₹0.30
- Book Value
- −₹3.03
- Market Cap
- —
- P/E (TTM)
- —
- P/B
- —
- ROE
- Not meaningful: shareholders’ equity is negative
- Dividend Yield
- 0.00%
- EBITDA
- −₹20.00 L
- 52W High
- —
- 52W Low
- —
Key Insights
No strengths listed
Weaknesses
2- Company has low interest coverage ratio.
- Promoter holding is low: 25.8%
Technical Indicators
| Group | Signal | Bearish | Neutral | Bullish |
|---|---|---|---|---|
| Overall | Strong Bullish | 4 | 3 | 12 |
| Oscillators | Bearish | 4 | 3 | 2 |
| Moving Averages | Strong Bullish | 0 | 0 | 10 |
Oscillators
Bearish
Bearish
4
Neutral
3
Bullish
2
Overall
Strong Bullish
Bearish
4
Neutral
3
Bullish
12
Moving Averages
Strong Bullish
Bearish
0
Neutral
0
Bullish
10
Key readings
- RSI (14)
- 69.51
- Neutral
- MACD (12,26,9)
- 0.73
- Bullish
- SMA (50)
- 12.59
- Bullish
- SMA (200)
- 15.37
- Bullish
As of , the latest day with price data, so these readings are not current.
Growth Rate
From the financial statements below. 10Y, 5Y, 3Y: compound annual growth to Mar 2026; 1Y: fiscal year to Mar 2026 against Mar 2025; TTM: four quarters to Jun 2026 against Jun 2025.
Revenue
| 10Y | −100.00% |
|---|---|
| 5Y | −100.00% |
| 3Y | Zero base |
| 1Y | Zero base |
| TTM | Zero base |
Net profit
| 10Y | Turned to loss |
|---|---|
| 5Y | Loss narrowed by ₹1 Cr |
| 3Y | Loss narrowed by ₹3.95 Cr |
| 1Y | Loss widened by ₹0.15 Cr |
| TTM | Loss widened by ₹0.13 Cr |
Operating cash flow
| 10Y | Turned negative |
|---|---|
| 5Y | Outflow narrowed by ₹0.13 Cr |
| 3Y | Turned negative |
| 1Y | Outflow narrowed by ₹0.07 Cr |
| TTM | — |
TTM: Reported once a year, so there is no trailing-twelve-month figure.
Operating margin· change in pp
| 10Y | No sales |
|---|---|
| 5Y | No sales |
| 3Y | No sales |
| 1Y | No sales |
| TTM | No sales |
Revenue by year
| Mar 2017 | ₹17.18 Cr |
|---|---|
| Mar 2018 | ₹8.10 Cr |
| Mar 2019 | ₹5.59 Cr |
| Mar 2020 | ₹6.59 Cr |
| Mar 2021 | ₹6.33 Cr |
| Mar 2022 | ₹0.74 Cr |
| Mar 2023 | ₹0.00 Cr |
| Mar 2024 | ₹0.00 Cr |
| Mar 2025 | ₹0.00 Cr |
| Mar 2026 | ₹0.00 Cr |
Net profit by year
| Mar 2017 | ₹0.01 Cr |
|---|---|
| Mar 2018 | ₹0.00 Cr |
| Mar 2019 | ₹0.03 Cr |
| Mar 2020 | −₹3.76 Cr |
| Mar 2021 | −₹1.28 Cr |
| Mar 2022 | ₹0.72 Cr |
| Mar 2023 | −₹4.23 Cr |
| Mar 2024 | −₹0.27 Cr |
| Mar 2025 | −₹0.13 Cr |
| Mar 2026 | −₹0.28 Cr |
Quarterly Results
₹ Cr| Particulars | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 0.08 | 0.03 | 0 | 0.07 | 0.1 | 0.07 | 0.1 | 0.06 | 0.03 | 0.05 | 0.03 | 0.08 | 0.04 |
| Operating Profit | −0.08 | −0.03 | 0 | −0.07 | −0.1 | −0.07 | −0.1 | −0.06 | −0.03 | −0.05 | −0.03 | −0.08 | −0.04 |
| Other Income | 0 | 0 | 0 | 0.03 | 0 | 0 | 0 | 0.25 | 0 | 0 | 0 | 0.01 | 0.12 |
| Interest | 0 | 0.03 | 0.03 | 0 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.03 | 0.04 | 0.04 | 0.05 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| PBT | −0.08 | −0.06 | −0.03 | −0.04 | −0.13 | −0.1 | −0.13 | 0.16 | −0.06 | −0.08 | −0.07 | −0.11 | 0.03 |
| Tax % | 0% | −16.67% | −33.33% | 0% | −7.69% | −10% | −7.69% | −31.25% | −16.67% | −12.5% | −14.29% | −9.09% | −33.33% |
| Net Profit | −0.08 | −0.05 | −0.02 | −0.04 | −0.13 | −0.09 | −0.12 | 0.21 | −0.05 | −0.07 | −0.06 | −0.09 | 0.04 |
| EPS (₹) | −0.14 | −0.09 | −0.03 | −0.07 | −0.22 | −0.15 | −0.21 | 0.36 | −0.09 | −0.12 | −0.1 | −0.15 | 0.07 |
Profit & Loss
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.36 | 16.94 | 17.18 | 8.1 | 5.59 | 6.59 | 6.33 | 0.74 | 0 | 0 | 0 | 0 | 0 |
| Expenses | 14.42 | 16.5 | 15.97 | 7.23 | 5.01 | 9.91 | 6.56 | 1.04 | 0.8 | 0.18 | 0.3 | 0.2 | 0.2 |
| Operating Profit | 0.94 | 0.44 | 1.21 | 0.87 | 0.58 | −3.32 | −0.23 | −0.3 | −0.8 | −0.18 | −0.3 | −0.2 | −0.2 |
| OPM % | 6.12% | 2.6% | 7.04% | 10.74% | 10.38% | −50.38% | −3.63% | −40.54% | — | — | — | — | — |
| Other Income | 0.08 | 0.1 | 0.08 | 0.21 | 0.25 | 0.26 | 0 | 1.33 | −3.35 | 0 | 0.25 | 0.01 | 0.13 |
| Interest | 0.48 | 0.44 | 0.32 | 0.34 | 0.07 | 0.02 | 0.03 | 0.01 | 0 | 0.12 | 0.16 | 0.13 | 0.16 |
| Depreciation | 0.51 | 0.09 | 0.96 | 0.73 | 0.73 | 0.42 | 1.02 | 0.35 | 0.09 | 0 | 0 | 0 | 0 |
| PBT | 0.03 | 0.01 | 0.01 | 0.01 | 0.03 | −3.5 | −1.28 | 0.67 | −4.24 | −0.3 | −0.21 | −0.32 | −0.23 |
| Tax % | 33.33% | 100% | 0% | 100% | 0% | 7.43% | 0% | −7.46% | 0% | −10% | −33.33% | −12.5% | — |
| Net Profit | 0.02 | 0.01 | 0.01 | 0 | 0.03 | −3.76 | −1.28 | 0.72 | −4.23 | −0.27 | −0.13 | −0.28 | −0.18 |
| EPS (₹) | 0.03 | 0.02 | 0.02 | 0 | 0.05 | −6.43 | −2.19 | 1.23 | −7.23 | −0.46 | −0.22 | −0.48 | −0.3 |
| Div. Payout % | 0% | 0% | 0% | — | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | — |
Balance Sheet
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 | 5.85 |
| Reserves | 1.21 | 1.21 | 1.19 | 1.18 | 1.18 | −2.64 | −3.92 | −3.2 | −7.42 | −7.22 | −7.34 | −7.62 |
| Borrowings | 9.25 | 9.01 | 9.94 | 11.32 | 5.35 | 2.85 | 2.5 | 1.32 | 1.33 | 1.36 | 1.49 | 1.8 |
| Other Liabilities | 2.32 | 2.34 | 3.97 | 5.01 | 9.46 | 1.52 | 1.2 | 0.91 | 0.31 | 0.06 | 0.08 | 0.04 |
| Total Liabilities | 18.63 | 18.41 | 20.95 | 23.36 | 21.84 | 7.58 | 5.63 | 4.88 | 0.07 | 0.05 | 0.08 | 0.07 |
| Fixed Assets | 10.08 | 10.27 | 12.68 | 12.45 | 11.99 | 4.78 | 3.64 | 4.43 | 0 | 0 | 0 | 0 |
| CWIP | 0.2 | 0.2 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 8.35 | 7.94 | 8.27 | 10.91 | 9.85 | 2.8 | 1.99 | 0.45 | 0.07 | 0.05 | 0.08 | 0.07 |
| Total Assets | 18.63 | 18.41 | 20.95 | 23.36 | 21.84 | 7.58 | 5.63 | 4.88 | 0.07 | 0.05 | 0.08 | 0.07 |
Cash Flow
₹ Cr| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating | 0.39 | 0.83 | 2.46 | 0.89 | −0.95 | −11.34 | −0.29 | 0.21 | 0.01 | −0.17 | −0.23 | −0.16 |
| Investing | −2.44 | −0.21 | −3.18 | −0.37 | −0.28 | 11.24 | 0.12 | 0 | 0 | 0 | 0 | 0 |
| Financing | 2.18 | −0.78 | 0.63 | 1.04 | −0.29 | −0.02 | −0.03 | −0.01 | 0 | 0.15 | 0.25 | 0.16 |
| Net Cash Flow | 0.12 | −0.15 | −0.09 | 1.56 | −1.51 | −0.12 | −0.21 | 0.2 | 0.01 | −0.02 | 0.02 | 0 |
| Free Cash Flow | −2.06 | 0.62 | −0.73 | 0.36 | −1.23 | −0.1 | −0.17 | 0.21 | 0.01 | −0.17 | −0.23 | −0.16 |
| CFO/OP | 41 | 189 | 203 | 102 | −164 | 342 | 126 | −70 | −1 | 94 | 110 | 80 |
Ratios
| Particulars | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 57.74 | 53.87 | 56.3 | 103 | 136 | 79.2 | 91.11 | 34.53 | — | — | — | — |
| Inventory Days | 77.67 | 46.15 | 55.54 | 181 | 833 | 81.53 | 46.98 | 198 | — | — | — | — |
| Days Payable | 43.12 | 41.39 | 49.24 | 63.34 | 437 | 41.89 | 28.91 | 342 | — | — | — | — |
| Cash Conversion Cycle | 92.3 | 58.62 | 62.6 | 221 | 532 | 119 | 109 | −110 | — | — | — | — |
| Working Capital Days | 24.71 | −6.46 | −29.53 | −140 | −318 | −72 | −66.89 | −765 | — | — | — | — |
| ROCE % | 3.39% | 2.84% | 2% | 1.98% | 0.59% | −40.35% | −23.83% | −10.95% | 5.9% | — | — | −1266.67% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Adline Chem Lab insights
61 extracted metrics across FY10–FY27.
Documents
- 29 May 2026
- General announcements 19 Oct 2026
- General announcements 12 Oct 2026
Frequently Asked Questions about Adline Chem Lab
What does Adline Chem Lab Ltd do?
Incorporated in 1988, Adline Chem Lab Ltd trades in pharmaceutical formulations, Nutraceutical, and Dietary products.
Where is Adline Chem Lab Ltd (ADLINE) listed?
Adline Chem Lab Ltd trades under code 524604 on the BSE.
Which sector does Adline Chem Lab Ltd belong to?
Adline Chem Lab Ltd is classified under the Healthcare sector, in the Pharmaceuticals industry.
Company Information
Incorporated in 1988, Adline Chem Lab Ltd trades in pharmaceutical formulations, Nutraceutical, and Dietary products.
Website kamronlabs.com
Face Value ₹10
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/524604.md for Adline Chem Lab Ltd: dated key facts, then this page's sections in order: latest price, key fundamentals, peer comparison, the Tapetide Score, technical indicators, analyst ratings, growth rates, analyst forecasts, the AI analysis and news digest (labelled as AI-generated), financial statements, shareholding pattern, documents and the FAQ.
Append .md to any Tapetide URL for
the same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.